New pill aims to tame painful lupus skin flares

NCT ID NCT07470970

First seen Mar 19, 2026

Summary

This study is testing whether a pill called enpatoran can safely reduce active skin rashes in people with lupus. About 202 participants with moderate-to-severe lupus skin symptoms will take either enpatoran or a placebo pill for 24 weeks, while continuing their standard lupus medications. The main goal is to see if the drug can significantly clear skin lesions and reduce symptoms like redness, scaling, and itch.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    Darmstadt, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.